Correlation Between Prostatype Genomics and ADDvise Group

Can any of the company-specific risk be diversified away by investing in both Prostatype Genomics and ADDvise Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prostatype Genomics and ADDvise Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Prostatype Genomics AB and ADDvise Group AB, you can compare the effects of market volatilities on Prostatype Genomics and ADDvise Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prostatype Genomics with a short position of ADDvise Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prostatype Genomics and ADDvise Group.

Diversification Opportunities for Prostatype Genomics and ADDvise Group

0.64

Correlation Coefficient

Prostatype Genomics  ADDvise Group

Poor diversification

The 3 months correlation between Prostatype and ADDvise is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Prostatype Genomics AB and ADDvise Group AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADDvise Group AB and Prostatype Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prostatype Genomics AB are associated (or correlated) with ADDvise Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADDvise Group AB has no effect on the direction of Prostatype Genomics i.e., Prostatype Genomics and ADDvise Group go up and down completely randomly.

Pair Corralation between Prostatype Genomics and ADDvise Group

Assuming the 90 days trading horizon Prostatype Genomics AB is expected to generate 3.37 times more return on investment than ADDvise Group. However, Prostatype Genomics is 3.37 times more volatile than ADDvise Group AB. It trades about 0.0 of its potential returns per unit of risk. ADDvise Group AB is currently generating about -0.08 per unit of risk. If you would invest  196.00  in Prostatype Genomics AB on April 23, 2025 and sell it today you would lose (88.00) from holding Prostatype Genomics AB or give up 44.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Prostatype Genomics AB  vs.  ADDvise Group AB

Prostatype Genomics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Prostatype Genomics AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Prostatype Genomics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

ADDvise Group AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days ADDvise Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Prostatype Genomics and ADDvise Group

The main advantage of trading using opposite Prostatype Genomics and ADDvise Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prostatype Genomics position performs unexpectedly, ADDvise Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADDvise Group will offset losses from the drop in ADDvise Group's long position.

The idea behind Prostatype Genomics AB and ADDvise Group AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.